These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 8380735)

  • 1. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A natural hepatocyte growth factor/scatter factor autocrine loop in myoblast cells and the effect of the constitutive Met kinase activation on myogenic differentiation.
    Anastasi S; Giordano S; Sthandier O; Gambarotta G; Maione R; Comoglio P; Amati P
    J Cell Biol; 1997 Jun; 137(5):1057-68. PubMed ID: 9166406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scatter factor/hepatocyte growth factor in brain tumor growth and angiogenesis.
    Abounader R; Laterra J
    Neuro Oncol; 2005 Oct; 7(4):436-51. PubMed ID: 16212809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional map and domain structure of MET, the product of the c-met protooncogene and receptor for hepatocyte growth factor/scatter factor.
    Gherardi E; Youles ME; Miguel RN; Blundell TL; Iamele L; Gough J; Bandyopadhyay A; Hartmann G; Butler PJ
    Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12039-44. PubMed ID: 14528000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the hepatocyte growth factor (HGF) receptor (Met) and presence of a truncated and activated intracellular HGF receptor fragment in locally aggressive/malignant human musculoskeletal tumors.
    Wallenius V; Hisaoka M; Helou K; Levan G; Mandahl N; Meis-Kindblom JM; Kindblom LG; Jansson JO
    Am J Pathol; 2000 Mar; 156(3):821-9. PubMed ID: 10702398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Src-mediated activation of alpha-diacylglycerol kinase is required for hepatocyte growth factor-induced cell motility.
    Cutrupi S; Baldanzi G; Gramaglia D; Maffè A; Schaap D; Giraudo E; van Blitterswijk W; Bussolino F; Comoglio PM; Graziani A
    EMBO J; 2000 Sep; 19(17):4614-22. PubMed ID: 10970854
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer.
    Wielenga VJ; van der Voort R; Taher TE; Smit L; Beuling EA; van Krimpen C; Spaargaren M; Pals ST
    Am J Pathol; 2000 Nov; 157(5):1563-73. PubMed ID: 11073815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deletion of the ectodomain unleashes the transforming, invasive, and tumorigenic potential of the MET oncogene.
    Merlin S; Pietronave S; Locarno D; Valente G; Follenzi A; Prat M
    Cancer Sci; 2009 Apr; 100(4):633-8. PubMed ID: 19175607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of c-Met in cancer: emphasis on lung cancer.
    Salgia R
    Semin Oncol; 2009 Apr; 36(2 Suppl 1):S52-8. PubMed ID: 19393836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 is required for two consecutive steps in HGF/c-Met signaling.
    Orian-Rousseau V; Chen L; Sleeman JP; Herrlich P; Ponta H
    Genes Dev; 2002 Dec; 16(23):3074-86. PubMed ID: 12464636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure of the tyrosine kinase domain of the hepatocyte growth factor receptor c-Met and its complex with the microbial alkaloid K-252a.
    Schiering N; Knapp S; Marconi M; Flocco MM; Cui J; Perego R; Rusconi L; Cristiani C
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12654-9. PubMed ID: 14559966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MET: a critical player in tumorigenesis and therapeutic target.
    Graveel CR; Tolbert D; Vande Woude GF
    Cold Spring Harb Perspect Biol; 2013 Jul; 5(7):. PubMed ID: 23818496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of the c-Met receptor tyrosine kinase in carcinogenesis and associated therapeutic opportunities.
    Zhang Y; Xia M; Jin K; Wang S; Wei H; Fan C; Wu Y; Li X; Li X; Li G; Zeng Z; Xiong W
    Mol Cancer; 2018 Feb; 17(1):45. PubMed ID: 29455668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation in the MET oncogene abrogates metastasis without affecting transformation.
    Giordano S; Bardelli A; Zhen Z; Menard S; Ponzetto C; Comoglio PM
    Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13868-72. PubMed ID: 9391119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between human airway epithelial cells and 3T3-J2 feeder cells involves partial activation of human MET by murine HGF.
    Hynds RE; Gowers KHC; Nigro E; Butler CR; Bonfanti P; Giangreco A; Prêle CM; Janes SM
    PLoS One; 2018; 13(5):e0197129. PubMed ID: 29771943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor-induced Ras activation requires ERM proteins linked to both CD44v6 and F-actin.
    Orian-Rousseau V; Morrison H; Matzke A; Kastilan T; Pace G; Herrlich P; Ponta H
    Mol Biol Cell; 2007 Jan; 18(1):76-83. PubMed ID: 17065554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative live imaging reveals a direct interaction between CD44v6 and MET in membrane domains upon activation with both MET ligands, HGF and internalin B.
    Tannoo RM; Richert L; Koschut D; Tomishige N; Treffert SM; Kobayashi T; Mély Y; Orian-Rousseau V
    Biochim Biophys Acta Biomembr; 2024 Jan; 1866(1):184236. PubMed ID: 37793560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MET exon 14 skipping mutation drives cancer progression and recurrence via activation of SMAD2 signalling.
    Liang Q; Hu Y; Yuan Q; Yu M; Wang H; Zhao B
    Br J Cancer; 2024 Feb; 130(3):380-393. PubMed ID: 38110666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Profiling the dynamics of a human phosphorylome reveals new components in HGF/c-Met signaling.
    Woodard CL; Goodwin CR; Wan J; Xia S; Newman R; Hu J; Zhang J; Hayward SD; Qian J; Laterra J; Zhu H
    PLoS One; 2013; 8(9):e72671. PubMed ID: 24023761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic targeting of the kinase activity of the Met receptor in cancer cells.
    Arena S; Pisacane A; Mazzone M; Comoglio PM; Bardelli A
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11412-7. PubMed ID: 17595299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.